As a result of gene expression that is regulated by HIF-1α, changes that promote tumor growth, such as adaptation of nutrient metabolism, hyperangiogenesis and enhancement of infiltration ability, occur [10, 11], and resistance to therapeutics such as chemotherapeutic agents and molecular targeted agents is acquired. The gene discussed is HIF1A; the disease is neoplasm.